|
 |
|
|
 |
|
Tim Lenihan
Partner |
|
|
 |
|
Bruce Meadows
Partner |
|
|
| Tim Lenihan is the Co-Founder and Partner of MD Start. Prior to founding MD Start, Tim was CEO and Founder of Contract Medical International GmbH (CMI) a contract developer and manufacturer of catheter based medical devices headquartered in Dresden Germany with facilities in both Germany and the Czech Republic. Tim has worked in various engineering and regulatory positions in the medical device industry over the last 23 years both in the US and Europe. He has worked with researchers, entrepreneurs and small companies to develop, obtain approval, manufacture and launch of variety of medical devices in the field of Critical Care Medicine, Interventional Cardiology and Radiology and Respiratory Care. |
|
Bruce Meadows is a Partner of MD Start and has been involved in the health care investment and medical device market place. Starting in 1999 with Rothschild and then GBS Ventures in Australia, Bruce has invested in many early stage medical companies. Bruce was a director of CogState and Pacific Knowledge Systems and most recently Italian imaging company, Esaote. After completing his MBA at IMD in Switzerland, he was responsible for Stryker Europe's thoracolumbar and less invasive spinal systems where he grew sales 21% to €35m and launched four new products into the marketplace. Prior to joining MD Start, Bruce was a Partner at Ares Life Science, a €1B healthcare fund based in Geneva. Bruce is now combining his investment experience with the device operating experience to help get brilliant medical technology to market sooner. |
|
 |
|
|
 |
|
Gérard Hascoët
Chairman of the Board |
|
|
 |
|
Stephen N. Oesterle M.D.
Director |
|
|
Gérard Hascoët, is an engineer graduated from E.C.E Paris. He began his career at CGR, the Medical Devices Subsidiary of the French Thomson Group, where he held various management positions over 14 years. In 1985 he founded Technomed International, a company developing non-invasive therapeutic technologies in the Urology domain. As CEO, he grew the company to its IPO in 1989 with € 40 million sales. In 1993 he founded 2 companies – IMMI, developing Neurosurgery image guided robotic systems and SOMETEC, developing non-invasive Hemodynamic monitoring in the domains of Anesthesiology and Intensive Care. IMMI was acquired in 1997 by ISS, a US based company, and SOMETEC was acquired in 2000 by Arrow International, a US medium-sized company listed on the NASDAQ.
Gérard Hascoët is now Chairman of the Board of SpineVision (France), Chairman of CorWave (France), Director of the Board of Dupont Medical (France) and Director of the Board of Altamir Amboise (France). Gérard is also Venture Partner for the French-based Venture Capital firm Sofinnova Partners. |
|
Dr. Stephen Oesterle joined Medtronic in 2002 as Senior Vice President for Medicine and Technology. In this role, he provides executive leadership for Medtronic scientific research, formation of technological strategies and continued development of strong cooperative relationships with the world's medical communities, technical universities, financial institutions and emerging medical device companies.
Previously, Dr. Oesterle served as Associate Professor of Medicine at the Harvard University Medical School and as Director of Invasive Cardiology Services at Massachusetts General Hospital, Boston. A teacher and innovator in the field of cardiac catheterization, he has also developed and directed interventional cardiology programs at Good Samaritan Hospital, Los Angeles; at Georgetown University; and at Stanford University.
He is a 1973 summa cum laude graduate of Harvard College and received his medical doctorate from Yale University in 1977. He completed his internship and residency at Massachusetts General Hospital and also served a fellowship in interventional cardiology at Stanford. |
|
 |
|
Antoine Papiernik
Director |
|
|
 |
|
Kirk Nielsen
Director |
|
|
| Antoine Papiernik is a Managing Partner at Sofinnova Partners in Paris. He invests in life sciences. He joined Sofinnova Partners in 1997, and was previously with CDC-Innovation, the venture arm of the Caisse des Dépôts group. Since joining Sofinnova Partners, Antoine has been an initial investor and active board member in companies like Actelion, Addex, Orexo and NovusPharma, which went public respectively on the Zürich stock exchange, the Stockholm stock exchange and the Milan Nuovo Mercato, in Cotherix (initially NASDAQ listed, then sold to Actelion) and CoreValve (sold to Medtronic). He has also invested in and is a board member of CoAxia, EOS, Fovea, Lectus, Movetis, SpineVision and Stentys. He has an MBA from the Wharton School of Business, University of Pennsylvania. |
|
Kirk Nielsen specializes in medical device and healthcare services investing at Versant. Kirk joined Versant from Medtronic. Most recently, he was a sales representative in the company's Cardiac Rhythm Management (CRM) division, where he was named a national sales rep of the year. Previously, he worked in marketing/business development for Medtronic CRM and Medtronic Neurological. Before Medtronic, Kirk spent time in marketing/business development at Fluidigm (a Versant portfolio company), and he also served as a strategy consultant at Bain & Company, where he advised clients in healthcare, private equity, and other industries. Prior to his business career, Kirk was a professional hockey player.
Kirk has served as a board member or observer at a number of Versant companies, including Cardiac Concepts, ConcepTx, Confirma (acquired), GluMetrics, IPS, Lutonix, MD Start, Portaero, RedBrick Health, Sequent Medical, The Innovation Factory, WaveTec, and Vital Therapies.
Kirk earned a biology degree with honors from Harvard College, where he won the John P. Reardon, Jr. award as the school's most outstanding scholar-athlete, and an MBA from Harvard Business School, where he was a Baker Scholar. |
|
 |
|
Edward S. Andrle
Director |
|
|
|
|
Ed Andrle is the Vice President of Business Development and Strategy for the Sorin Group in Milan, Italy. Prior to Sorin, Mr. Andrle co-founded, developed, and sold three medical device companies in the Minneapolis area. Teramed was focused on an endovascular system to treat abdominal aortic aneurysms and was acquired by Johnson&Johnson. Myocor developed an implantable device to treat mitral valve regurgitation and was acquired by Edwards. And StarFire Medical developed technology to treat brain aneurysms and was acquired by NFocus Neuromedical.
Mr. Andrle also spent five years as a Vice President of Boston Scientific. Mr. Andrle lead a new business unit that developed a number of peripheral vascular catheters and guidewires that eventually accounted for over $100 million in sales for Boston Scientific. He also worked for Institutional Venture Partners in medical device investments and spent five years at Baxter International working in marketing in the renal therapy business. He has an MBA from the Stanford Graduate School of Business and a BS in Chemical engineering from the University of Notre Dame. |
|
|
|
|
|
